biguanides has been researched along with Pyoderma in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Pyoderma: Any purulent skin disease (Dorland, 27th ed).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsiao, YH | 1 |
| Imanishi, I | 1 |
| Iyori, K | 1 |
1 trial available for biguanides and Pyoderma
| Article | Year |
|---|---|
Efficacy of olanexidine gluconate in canine superficial pyoderma: a randomised, single-blinded controlled trial.
Topics: Animals; Anti-Bacterial Agents; Biguanides; Dog Diseases; Dogs; Glucuronates; Microbial Sensitivity | 2021 |